Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Burden of diseases attributable to second-hand smoke exposure in Iran adolescents from 2009 to 2020.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • المصدر:
      Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE
    • بيانات النشر:
      Original Publication: London : Nature Publishing Group, copyright 2011-
    • الموضوع:
    • نبذة مختصرة :
      Exposure to second-hand smoke (SHS) is prevalent in many countries, but the problem's scope is poorly understood globally, especially in developing countries. We aimed to estimate SHS exposure and its national and subnational burden of diseases in Iran, the second-largest country in the Middle East, during 2009-2020. The burden of diseases from SHS was estimated as disability-adjusted life years (DALYs) for adolescents (10-18) year's non-smokers. Using comparative risk assessment methodologies, the calculations were based on disease-specific relative risk estimates with national and subnational SHS exposure data, and the uncertainty and sensitivity analysis was performed. The results of study showed that the trend of exposure to SHS is increasing in Iran. The highest DALY was related to lower respiratory infection (LRI), asthma, and otitis media, respectively. The national average asthma burden (DALY/100,000) has increased from 17.4 (11.8_23.9) in 2009 to 21.3 (13.9_30) in 2020, LRI decreased from 25.8 (21.5_30.2) to 19.8 (16.7_23.1), and national average burden of otitis media (DALY/100,000) has increased from 3.1(1.9_4.6) to 3.9(2.4_5.6). The increasing trend of otitis media and asthma DALYs attributable to SHS exposure in Iran requires more attention from policymakers to protect the population.
      (© 2023. Springer Nature Limited.)
    • References:
      BMJ Open. 2017 Feb 14;7(2):e012694. (PMID: 28196944)
      J Pediatr Health Care. 2018 Nov - Dec;32(6):612-619. (PMID: 30064929)
      Int J Pediatr Otorhinolaryngol. 2006 Jul;70(7):1251-6. (PMID: 16481051)
      Environ Res. 2019 Mar;170:110-121. (PMID: 30579160)
      Lancet. 2015 Sep 12;386(9998):1075-85. (PMID: 26382999)
      J Diabetes Metab Disord. 2019 Aug 30;18(2):401-408. (PMID: 31890665)
      Environ Sci Pollut Res Int. 2021 Jan;28(3):2608-2625. (PMID: 33140301)
      Int J Prev Med. 2013 Dec;4(12):1451-60. (PMID: 24498502)
      Environ Res. 2021 Nov;202:111631. (PMID: 34224711)
      Int Forum Allergy Rhinol. 2015 Sep;5 Suppl 1:S11-6. (PMID: 26335830)
      CMAJ. 2009 Oct 27;181(9):E181-90. (PMID: 19752106)
      Int J Pediatr Otorhinolaryngol. 2012 Jul;76(7):989-93. (PMID: 22510576)
      Ann Allergy Asthma Immunol. 2015 Nov;115(5):396-401.e2. (PMID: 26411971)
      PLoS One. 2014 Jan 23;9(1):e86397. (PMID: 24466073)
      Environ Int. 2018 Dec;121(Pt 1):491-506. (PMID: 30286426)
      J Res Med Sci. 2012 Mar;17(3):293-7. (PMID: 23267383)
      PLoS One. 2016 Oct 6;11(10):e0163926. (PMID: 27711178)
      Front Pediatr. 2019 Jun 18;7:246. (PMID: 31275909)
      J Formos Med Assoc. 2011 Sep;110(9):555-63. (PMID: 21930065)
      Environ Health. 2017 Feb 23;16(1):14. (PMID: 28231798)
      Lancet Infect Dis. 2020 Jan;20(1):60-79. (PMID: 31678026)
      Respir Med. 2019 Jul - Aug;154:34-39. (PMID: 31207539)
      Environ Sci Pollut Res Int. 2021 Sep;28(34):46838-46851. (PMID: 34245414)
      Chronic Dis Transl Med. 2016 Nov 02;2(2):120-128. (PMID: 29063032)
      Arch Iran Med. 2020 Jun 01;23(6):369-377. (PMID: 32536173)
      Lancet. 2011 Jan 8;377(9760):139-46. (PMID: 21112082)
      MMWR Morb Mortal Wkly Rep. 2007 Jul 20;56(28):705-8. (PMID: 17637596)
      BMC Pediatr. 2012 Nov 29;12:185. (PMID: 23190626)
      Tob Control. 2005 Jun;14(3):181-5. (PMID: 15923468)
      Lancet Infect Dis. 2018 Nov;18(11):1191-1210. (PMID: 30243584)
      Eur J Intern Med. 2019 Mar;61:81-87. (PMID: 30391165)
      Environ Res. 2016 Jul;148:421-428. (PMID: 27131796)
      Int J Prev Med. 2012 Jun;3(6):394-401. (PMID: 22783465)
      Prev Med. 2019 Dec;129:105833. (PMID: 31505203)
      Int J Prev Med. 2017 Jan 23;8:4. (PMID: 28217266)
      NPJ Prim Care Respir Med. 2016 Nov 17;26:16067. (PMID: 27853176)
      Pediatr Pulmonol. 2020 Oct;55(10):2518-2531. (PMID: 32667747)
      Lancet Glob Health. 2016 Nov;4(11):e795-e805. (PMID: 27697484)
      Prev Med. 2019 Jun;123:34-40. (PMID: 30817956)
      J Asthma Allergy. 2021 Oct 28;14:1277-1284. (PMID: 34737580)
    • الرقم المعرف:
      0 (Tobacco Smoke Pollution)
    • الموضوع:
      Date Created: 20230821 Date Completed: 20230823 Latest Revision: 20231123
    • الموضوع:
      20231123
    • الرقم المعرف:
      PMC10442427
    • الرقم المعرف:
      10.1038/s41598-023-40058-z
    • الرقم المعرف:
      37604845